Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.32 |
| ▸ | DRD2 | P14416 | 2/20 | 0.31 |
| ▸ | DRD3 | P35462 | 2/20 | 0.31 |
| ▸ | HTR1A | P08908 | 1/20 | 0.31 |
| ▸ | CA12 | O43570 | 1/20 | 0.31 |
| ▸ | CA2 | P00918 | 1/20 | 0.31 |
| ▸ | CA9 | Q16790 | 1/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.30 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.30 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.30 |
| ▸ | DRD1 | P21728 | 1/20 | 0.30 |
| ▸ | DRD4 | P21917 | 1/20 | 0.30 |
| ▸ | DRD5 | P21918 | 1/20 | 0.30 |
| ▸ | ADRA1D | P25100 | 1/20 | 0.30 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.30 |
| ▸ | ADRA1B | P35368 | 1/20 | 0.30 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.30 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12514925 | 0.97 | HRH3 (0.33) | HRH3DRD2DRD3HTR1ACA12 | |
| SCHEMBL25985028 | 0.85 | — | — | |
| SCHEMBL10787449 | 0.83 | HRH3 (0.39) | HRH3DRD2DRD3HTR1ACA12 | |
| SCHEMBL308780 | 0.83 | HRH3 (0.39) | HRH3DRD2DRD3HTR1ACA12 | |
| SCHEMBL14270553 | 0.83 | HRH3 (0.39) | HRH3DRD2DRD3HTR1ACA12 | |
| SCHEMBL756023 | 0.83 | HRH3 (0.39) | HRH3DRD2DRD3HTR1ACA12 | |
| SCHEMBL12552538 | 0.79 | LMNA (0.31) | — | |
| SCHEMBL5358 | 0.79 | HRH3 (0.41) | HRH3DRD2DRD3HTR1ACA12 | |
| SCHEMBL2729745 | 0.79 | HRH3 (0.41) | HRH3DRD2DRD3HTR1ACA12 | |
| SCHEMBL21224483 | 0.79 | HRH3 (0.41) | HRH3DRD2DRD3HTR1ACA12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230173082-A1 | ANTIBACTERIAL PRODUCTS | UNIVERSITY OF LINCOLN (GB) | 2023-06-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230173082-A1 | ANTIBACTERIAL PRODUCTS | XIAP, CLSPN, SLC47A2 | HRH3 3565/4885DRD2 3707/4885DRD3 3587/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.